T-cell prolymphocytic leukaemia and Death - from FDA reports

Summary

Death is found among people with T-cell prolymphocytic leukaemia, especially for people who are male, 60+ old, take medication Campath and have Preventive health care. This review analyzes which people have Death with T-cell prolymphocytic leukaemia. It is created by eHealthMe based on reports of 12 people who have T-cell prolymphocytic leukaemia from FDA , and is updated regularly.

What to expect?

If you have T-cell prolymphocytic leukaemia and Death, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have T-cell prolymphocytic leukaemia and Death

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 18, 2017

12 people who have T-Cell Prolymphocytic Leukaemia and Death are studied.


Number of reports submitted per year:

Would you have Death when you have T-cell prolymphocytic leukaemia?

Gender of people who have T-Cell Prolymphocytic Leukaemia and experience Death *:

  • female: 36.36 %
  • male: 63.64 %

Age of people who have T-Cell Prolymphocytic Leukaemia and experience Death *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 18.18 %
  • 40-49: 0.0 %
  • 50-59: 9.09 %
  • 60+: 72.73 %

Top co-existing conditions for these people *:

  • Preventive Health Care (3 people, 25.00%)
  • Oedema (2 people, 16.67%)
  • Agitation (2 people, 16.67%)
  • Hepatitis B (1 person, 8.33%)
  • Diabetes (1 person, 8.33%)

Most common drugs for these people *:

  • Campath (7 people, 58.33%)
  • Tylenol (2 people, 16.67%)
  • Torsemide (2 people, 16.67%)
  • Fluconazole (2 people, 16.67%)
  • Famvir (2 people, 16.67%)

Top symptoms for these people *:

  • Thrombocytopenia (3 people, 25.00%)
  • Pleural Effusion (3 people, 25.00%)
  • Lymph Follicular Hypertrophy (2 people, 16.67%)
  • Haemothorax (2 people, 16.67%)
  • General Physical Health Deterioration (2 people, 16.67%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Death and T-cell prolymphocytic leukaemia?

Expand the study to include reports from both FDA and eHealthMe

Death and T-cell prolymphocytic leukaemia from FDA and eHealthMe reports

T-Cell Prolymphocytic Leukaemia

T-cell prolymphocytic leukaemia (a aggressive type of t cell cancer) (latest reports from 173 T-cell prolymphocytic leukaemia patients)

Death

Death has been reported by people with multiple myeloma, primary pulmonary hypertension, chronic myeloid leukaemia, diabetes, multiple sclerosis (latest reports from 386,249 Death patients).

Browse all symptoms of T-cell prolymphocytic leukaemia

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Death

Death

Other conditions that could case Death

Death

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have T-cell prolymphocytic leukaemia and Death.

Can you answer these questions?

More questions >

You may be interested in these reviews

More reviews >